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Limb-girdle muscular dystrophies (LGMD) are a heterogeneous group of genetically determined muscle disor-
ders witha primary or predominant involvement of the pelvic or shoulder girdle musculature. More than 20 genes
with autosomal recessive (LGMD2A to LGMD2Q) and autosomal dominant inheritance (LGMD1A to LGMD1H)
have been mapped/identified to date. Mutations are known for six among the eight mapped autosomal dominant
forms: LGMD1A (myotilin), LGMD1B (lamin A/C), LGMD1C (caveolin-3), LGMD1D (desmin), LGMD1E (DNAJB6),
and more recently for LGMD1F (transportin-3). Our group previously mapped the LGMD1G gene at 4q21 in a
Caucasian-Brazilian family. We now mapped a Uruguayan family with patients displaying a similar LGMD1G
phenotype at the same locus. Whole genome sequencing identified, in both families, mutations in the
HNRPDLgene. HNRPDL is a heterogeneous ribonucleoprotein family member, which participates in mRNA bio-
genesis and metabolism. Functional studies performed in S. cerevisiae showed that the loss of HRP1 (yeast
orthologue) had pronounced effects on both protein levels and cell localizations, and yeast proteome revealed
dramatic reorganization of proteins involved in RNA-processing pathways. In vivo analysis showed that hnrpdl
is important formuscledevelopment inzebrafish,causingamyopathicphenotypewhenknockeddown. Thepre-
sent study presents a novel association between a muscular disorder and a RNA-related gene and reinforces the
importance ofRNA binding/processing proteins inmuscle developmentand muscle disease.Understanding the
role of these proteins in muscle might open new therapeutic approaches for muscular dystrophies.
INTRODUCTION
The limb-girdle muscular dystrophies (LGMDs) are a heteroge-
neous group of genetically determined progressive disorders of
the muscle with a primary or predominant involvement of the
pelvic or shoulder girdle musculature. Mutations in .20 genes
with autosomal recessive (LGMD2A-Q) and autosomal domin-
ant inheritance (LGMD1A-H) have been mapped/identified to
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date (1–6). The autosomal dominant forms are relatively rare
and represent ,10% of all LGMD (2). Among the eight auto-
somal dominant forms that have been mapped, only six genes
have been identified to date: LGMD1A (myotilin), LGMD1B
(lamin A/C), LGMD1C (caveolin-3), LGMD1D (desmin),
LGMD1E (DNAJB6) and more recently LGMD1F
[transportin-3 (TNPO)] (5,6). The causal genes still remained
unknown for LGMD1G and LGMD1H (3).
We have previously mapped LGMD1G at 4q21 in a four-
generation Brazilian family of European ancestry, with a
maximum logarithm of odds (LOD)-score of 6.6. The disease
was characterized by late and variable muscular weakness. The
initial symptoms were proximal lower limbs involvement and
weakness followedbyupper limbsproximalweakness.Asdetailed
in the first report (4), limitation of finger and toe flexion was also
a characteristic of this condition. Type II diabetes was seen in 5
out of 10 patients, but also in three unaffected family members.
No cataracts, clinical myotonia or electroneuromyography-
detected myotonic phenomena were found when the family
was first described. Biceps muscle biopsy taken from one more
severely affected patient showed a predominantly myopathic
histopathological pattern associated with rimmed vacuoles (4).
Subsequently, we have identified a genealogy from Uruguay
with 18 affected members by an autosomal dominant form of
LGMD1G which was mapped in the same region. Whole
genome sequencing allowed us to identify the mutation in both
families in the HNRPDL gene.
RESULTS
Mapping and clinical findings
The genealogies of the Brazilian and Uruguayan families are
depicted in Figure 1A and B, respectively.
Linkageanalysis in theunrelatedLGMD1GUruguayan family,
using flankingmicrosatellite markers for the 4q21 region showed
a maximum LOD-score of 4.8 also at 4q21. Just like the original
Brazilian family, theUruguayan clinically affectedmembers pre-
sented an adult-onset diseasewith proximal limb-girdleweakness
that includedfinger and toeflexion limitation. In8out of 11 exam-
ined patients, the onset was in proximal lower limbs involving
subsequently theupper limbs. In three of them it startedwith prox-
imalweakness in theupper limbs (difficulty to raise the arms).The
age of onset varied from 15 to 53 years old (36.6+13.7). As an
additional phenotype, 6 out of 11 clinically affected individuals
presented cataracts (three bilateral and three unilateral) with
onset before the age of 50. Type II diabetes, with onset at the
age of 53, was present in one patient. A careful clinical and
neurological examination revealed that none of the patients had
myotonic phenomena.
In the Brazilian family, there are 17 affectedmembers distrib-
uted in three generations (Fig. 1A), and at least two asymptom-
atic cases: II-2 died in her 90s and never showed any muscular
weakness; her son, III-1 who should also be a carrier of the mu-
tation died at the age of 63 without any reported symptoms.
Three additional asymptomatic individuals carried the causative
variant; IV-23, IV-25 and V-1, but they are still within the range
of age of onset (30–47 years old). Recently, two patients
presented bilateral cataract with onset at ages 35 and 56 years.
In theUruguayan family (Fig. 1B), there are 18 affected patients.
Here, also three clinically unaffected members (III-5, IV-1 and
IV-7) were found to carry the causative variant but were still
within the age of manifestation when examined. Nonetheless,
it is clear from both families that the disease progresses with
age in most patients with no evidence of clinical anticipation,
does not display full penetrance and that both sexes are equally
affected.
Two distinct mutations in the same codon
The combined analysis of both families reduced the candidate
region to ,3.5 MB (positions 81 985 539 to 85 468 682 in Uni-
versity of California Santa Cruz (UCSC) Human Genome v19).
Whole genome sequencing was undertaken for three affected
patients (two Brazilian and one Uruguayan) by an Illumina
HiSeq2000 platform. In each family, a different variant in
chromosome 4, position 83 347 676 was identified (Supplemen-
taryMaterial, Table S1). The base is locatedwithin theHNRPDL
gene (heterogeneous nuclear ribonucleoprotein D-like), also
known as JKTBP (NM_031372.3, c.1667, p.D378). The muta-
tion in exon 6 was G . A (p.D378N) in the Brazilian family,
causing an amino acid change from aspartate to asparagine,
while in the Uruguayan family the mutation was G . C
(p.D378H), causing a change to histidine (Fig. 1C). Thesemuta-
tions were confirmed using Sanger sequencing in 13 Brazilian
(10 affected and 3 asymptomatic) and 12 Uruguayan (9 affected
and 3 asymptomatic) members and neither present in 14 non-
affected adult members from both families nor in 604 Brazilian
controls older than 60. The conservation profile of the residue
was performed in PolyPhen2 (7) and its alignment is indicated
inSupplementaryMaterial, FigureS1. Sequencingof 70 isolated
undiagnosed LGMD cases from Brazil or atypical forms of
myotonic-like phenotype failed to identify any furthermutations
in the HNRPDL gene.
Loss of hrp1 in yeast affects RNA-processing proteins
TheyeastHNRPDLorthologue is calledhrp1.These proteins are
42% identical over a 66% query cover of the human protein
(P-value of 1e-45) with overlaps in functions, as shown by a
Gene Ontology enrichment analysis (Supplementary Material,
Table S2). Using automated mating technologies, we assessed
the loss of HRP1 on the levels and localization of all yeast pro-
teins (8,9). A mutation in Dhrp1 was introduced into almost
6000 yeast strains each carrying a fusion of one yeast protein
with a c-terminal Green fluorescent protein (GFP) tag (10).
The hrp1 mutation had pronounced effects on both protein
levels and cell localizations demonstrating that loss of this
protein is detrimental to cellular physiology. Interestingly, the
loss of HRP1 on the yeast proteome revealed dramatic reorgan-
ization of proteins involved in RNA-processing pathways. The
RNA helicases Prp43 and Dbp2, which are both involved in
rRNA maturation, were completely excluded from their
natural place in the nucleolus and now reside in the cytosol ren-
dering them, most probably, inactive. A similar phenotype was
observed for Urb2, a nucleolar protein required for normal me-
tabolism of the rRNA primary transcript (Fig. 2). In addition, a
large number of proteins were up-/down-regulated indicating
the extent of cellular stress (SupplementaryMaterial, Table S3).
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Hnrpdl is important for zebrafish muscle development
To analyse the in vivo role ofHNRPDL inmuscle, we used a loss
of function approach in zebrafish. Fish hnrpdl (GenBank Acces-
sion: NP_998557.1) was found to have 85% identity with the
human sequence. An antisense oligonucleotide morpholino
(MO) was designed to specifically target the translation start
site of hnrpdl. Wild-type (AB) zebrafish embryos were injected
with a translation blocking MO designed to knockdown hnrpdl
expression in parallel with a control MO. Microinjection
hnrpdlMOat the one-cell stage leads to a dose-dependent down-
regulation of the expression of the hnrpdl gene (Fig. 3A).
Injected fish were quantified 4 days post-fertilization (4 dpf)
based on abnormal phenotypes (Fig. 3B). Depending on MO
dosage, injected embryos showed a range of severity such as
body shape defects or twisted tails (Fig. 3C). Additionally,
movements of hnrpdl morphants were restricted and uncoordin-
ated, which is consistent with a myopathy. Immunohistochem-
ical staining of MO injected fish showed abnormalities in the
V-shaped chevron pattern typically associated with a normal
fish. Themyofibreswere also disorganized as shown by birefrin-
gence andmyosin heavy chain (MCH) immunofluorescence (IF)
(Fig. 3D).
LGMD1G patients show diffuse HNRPDL in their muscle
Muscle histological features revealed variable findings appar-
ently related to the progression of the disease in two patients
from the Brazilian family (Fig. 4A). While the most severely
affected case (IV-9) showed a clear myopathic pattern, with de-
generation, fibre size variation with discrete perimysial fibrosis,
several necrotic fibres and rimmed vacuoles, the other less
severely affected (III-33) showed an almost normal histological
pattern. Furthermore, evidence of neurogenic involvement was
observed in both patients, including the presence of small angu-
lated fibres, predominance of type II fibres and a discrete fibre
type grouping pattern on the ATPases reaction, compatible
with a neurogenic involvement.
Immunohistochemical and western blot (WB) analyses
revealed normal pattern for dystrophin, calpain3, dysferlin, tele-
thonin and a-,b-sarcoglycans [previously shown in our original
report (4)] and g-sarcoglycans as shown in Figure 4A.
Since HNRPDL is a candidate to physically interact with
TNPO1 in RNA-processing events (11,12) analysing the distri-
bution patterns of these proteins in the muscle of patients
versus controls is of great interest.
Immunohistochemical analysis identified the presence of
HNRPDL protein in the nuclei of the control as well as in
patients, co-localizing with TNPO1 (Fig. 4B). However, an
apparently higher variability in nuclear labelling was observed
in the patients: some nuclei presented a strong condensed
HNRPD-L labelling while in others, HNRPDL showed a dif-
fused pattern around the nuclei more frequently than the
observed in normal muscle. Interestingly, a similar observation
was previously reported in conditionswhere there is no transpor-
tation of HNRPDL by TNPO1 (11).
DISCUSSION
HNRPDL is a heterogeneous ribonucleoprotein (hnRNP) family
member, along with HNRNPD, HNRNPL, SRSF3 and PTBP1.
This family has been shown to function in mRNA biogenesis
and mRNA metabolism, including alternative splicing, mRNA
Figure 1.Thick segments under individual numbers indicatemutated and thin segments indicate non-mutated, according to Sanger sequencing. (A) Pedigree of Bra-
zilian family. Proband (arrow): IV-5.Mutated (Sanger) (NM_031372.3 c.1667G.A) and symptomatic: II-11, III-19, III-27, III-33, III-36, III-38, III-40, IV-5, IV-7,
IV-27.Mutated and asymptomatic: IV-23, IV-26, V-1. Non-mutated: II-8, III-12, III-14, III-16, III-22, III-31, III-43, IV-12. Biopsies were done in III-31, III-33 and
IV-9. (B) Pedigree of Uruguayan family. Proband (arrow): IV-5. Mutated (Sanger) (NM_031372.3 c.1667G.C) and symptomatic: III-2, III-3, III-4, IV-5, IV-8,
IV-10, IV-12, IV-15, V-1. Mutated and asymptomatic: III-5, IV-1, IV-7. Non-mutated: III-12, IV-2, IV-9, IV-13, V-3, V-4. (C) Eletropherogram regions containing
alterations in Uruguayan and Brazilian affected family members compared with a healthy control.
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nuclear export, translational regulation and turnover (11).
HNRPDs participate in the splicing of specific exons in
pre-mRNA of transcripts from important muscle-related
genes. HnRNPF, hnRNPG and hnRNPH regulate alternative
splicing of alpha- and beta-tropomyosin and hnRNPG is also
involved in dystrophin splicing (13). HnRNPA1 and hnRNP
A/B interact with PABPN1, a gene that when mutated causes
adult-onset oculopharyngeal muscular dystrophy (OPMD). In
OPMD patients, hnRNPA1 is sequestered in intranuclear insol-
uble aggregates interferingwithRNAexport and causingmuscle
cell death (14). Abnormal hnRNPH also inhibits nuclear export
of mRNA containing expanded CUG repeats (15) and is also
associated with aberrant splicing in myotonic dystrophy type 1
(16). Cataracts, a feature of the myotonic dystrophy spectrum,
were the present in six members of the Uruguayan LGMD1G
family and more recently in two of the Brazilian family.
Interestingly, Drosophila smooth gene mutant, orthologue of
the mammalian hnRNPL, shows decreased motor function and
a progressive dystrophic muscle phenotype (17). Our in vivo
study in zebrafish showed that movements of hnrpdl morphants
were restricted and uncoordinated, especially in response to
touch, which supports the importance of hnrpdl inmuscle devel-
opment and function, consistent with a myopathy (18). Thus,
our findings reinforce the role of the hnRNP family in muscle
pathology.
Additionally, our functional studies show the importance of
hnrpdl in RNA-processing pathways in yeast. Interestingly, the
diffuse hrp1 labelling found in the yeast mutant was also
observed in the nucleus of LGMD1G patients’ muscle fibres,
which might suggest an impaired traffic of the mutant
HNRPDL into the nuclei. Recently, TNPO3 was identified as
the gene responsible for LGMD1F. It belongs to a family of
importin b super-family proteins that import numerous proteins
into thenucleus, including serine/arginine-rich proteins (SRpro-
teins) that control mRNA splicing (5,6). On the other hand
TNPO1 mediates the nuclear import of M9-bearing proteins
and has been shown to bind the nuclear localization signal in
the C-terminal of HNRPDL (11,12). LGMD1F and 1G might
share a common and novel pathological mechanism, still unre-
lated to the known LGMD molecular mechanisms.
In conclusion, we have identified mutations in HNRPDL
associated with LGMD1G. We also provide evidence that the
impairment of HNRPDL homologues cause a rearrangement
of RNA-related proteins both in localization and level para-
meters in yeast and a muscular phenotype in zebrafish. Our
study may provide a link between this disease and the group of
myopathies caused by impaired RNA binding/processing pro-
teins, which had been previously associated with oculopharyn-
geal muscular dystrophy as well as myotonic dystrophies type
1 and 2, disorders caused by dynamic mutations. This work sig-
nificantly contributes to our understanding of inheritedmuscular
dystrophies.
MATERIAL AND METHODS
The study was approved by the institutional ethics committee
and all patients signed informed consent forms.
Muscle IF analyses
From the Brazilian family, a muscle biopsy was taken from
biceps muscle from the index case affected brother at the age
of 38 (patient IV-3, Fig. 1), and from one additional affected
relative (II-33). The muscles were cryo-protected and snap
frozen in liquid nitrogen. Routine histological and histochem-
ical analyses include staining for HE, modified Gomori tri-
chrome, SDH, NADH, acid phosphatases and ATPase at pH
9.4 and 4.3.
Protein analyses were done through IF and WB methodolo-
gies, as previously described (4). The following antibodies
Figure 2. Images of seven proteins involved inRNAprocessing, whose localiza-
tionwas shifted in the absence ofHRP1.Anullmutation inHRP1was introduced
into almost 6000 yeast strains each carrying a fusion of one yeast protein with a
c-terminal GFP tag. All proteins levels and localizations were followed and
mutants (right column) were compared with control cells with a normal copy
of HRP1 (left column). Loss of HRP1 caused a dramatic reorganization in the
subcellular localization of proteins involved in RNA-processing pathways dem-
onstrating a central role for this protein in determining RNA-processing physi-
ology. Loss of the HRP1, the yeast homologue of HNRPDL, causes dramatic
changes in the localization of proteins required for RNA processing.
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were used: dystrophin, sarcoglycans a, b, g and d, calpain-3,
dysferlin and telethonin. Additionally, the following primary
antibodies were used: polyclonal rabbit anti-HNRPDL (1/100,
Sigma), monoclonal anti- TNPO1 (1/20, Novus Biologicals).
As secondary antibodies, anti-mouse-FITC and anti-rabbit-Cy3
(Sigma) in the concentration of 1/100 were used.
Figure 3. hnrpdl knockdown in zebrafish. (A)Western blot confirming a dose-dependent hnrpdlMOknockdownwith either 6, 9 or 12 ng hnrpdl translation blocking
MO.Beta-actinwas used as a loading control. (B) Injected fishwere quantified 4 days post-fertilization (4dpf) based on abnormal phenotypes, whichwere defined by
body shape defects like shortened or twisted tails, and swimming impairments, such as slow motility in response to touch, or rotating in circles. Compared with fish
injected with control MO, hnrpdl morphants were more abnormal in the 9 ng concentration, while the number of dead embryos increased at the 12 ng concentration,
which is likely due to toxicity. Three separate experiments were performed; graph shows the average number of fish per group. (C) Phase images of injected fish with
hnrpdlMO (9 ng) and controlMO.Note abnormal body shape seen inmajority of injected fish. (D) Phase image, birefringence and IF stainingwithMCHantibody of
hnrpdl knockdown in zebrafish. Note the dose-dependent effect of low birefringence and disorganized muscle fibres in the hnrpdl morphant fish muscle when com-
paredwith the controlMOand non-injectedfish (n ¼ 10).Non-injected, ABzebrafish; CoMo, controlmorpholino injectedfish; TBMO, translational blocking hnrpdl
MO; ng, nanograms.
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Genome sequencing
DNAwas isolated from the blood by the standard methodology.
Libraries were subsequently sequenced as 100-base paired-end
runs (average insert size of 300 bases). Read alignment and
variant calling was performed by the Illumina CASAVA 1.9
pipeline software. An average of 120 GB in aligned sequences
was produced per sample, yielding a genome sampling depth
of 40× and .95% of the UCSC hg19 reference genome
sampled at 10 reads ormore.Moreover, sampleswere genotyped
using the HumanOmni2.5-8v1 microarray. NGS alignment and
genotyping pipelinewas also redoneusingBroad Institute’sBest
Practices (BWA 0.7; GATKv2.4; HaplotypeCaller), but no
further variants in the linked region were identified.
As a downstream variant analysis, the resulting variant list for
each sample was filtered using the 1000 Genomes variants
(phase 1 release v3), the NHLBI Exome Sequencing Project
(ESP6500) variants and 604 high-coverage exomes from
randomized, population-based Brazilian controls. Variants
withminor allele frequency.0.01were removed fromanalysis.
Insertion of Dhrp1 into the yeast GFP library expressing
cytosolic mCherry
The synthetic genetic array (SGA) technique was performed
between aMATa haploid strain harbouring theDhrp1::kanR de-
letion from the deletion library collection (19) and the GFP col-
lection (::HIS3) (10) expressing a TEF2pr-mCherry::URA3
integrated into the URA3 locus (20). In this collection of
strains, a GFP was integrated carboxy-terminally into the
genomic locus of each yeast open reading frame, maintaining
the chromosomal context and preserving the natural promoter
of each gene. The cytosolic fluorescence allows us to segment
the images into hundreds of individual yeast cells for each
strain and to extract protein abundance (detected as GFP
Figure 4.Muscle analyses in twoBrazilian affectedmembers. (A)HE staining showinghistopathological alterations in patient IV-9 and in less affected patient III-33,
as comparedwith anormal control, andan immunohistochemical reaction forg-SG to illustrate thepatternof sarcolemmal labelling.Magnification: 200×. (B)Double
immunohistohemical analysis forHNRPDLandTNPO1.Magnification 400×. Arrow showingnucleiwith peripheral diffused labelling, anddetail showing a nucleus
with strong condensed labelling.
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fluorescence) under the desired condition. Mating was per-
formed on rich-media plates, selection for diploid cells was per-
formed on plates lacking both HIS and URA and containing
G418. Sporulation was then induced by transferring cells to ni-
trogen starvation plates for 5 days. Haploid cells containing all
desired mutations were selected by transferring cells to plates
containing all selection markers alongside the toxic amino acid
derivatives Canavanine and Thialysine (Sigma-Aldrich) to
select against remaining diploids and lacking leucine to select
for only spores with an ‘alpha’ mating type (8,9). The SGA pro-
cedure was validated by inspecting representative strains for the
deletion and the presence of the GFP-tagged strains and for the
cytosolic mCherry expression. To manipulate the collection in
high-density format (384), we used a RoToR bench top colony
arrayer (Singer Instruments, UK).
High-throughput fluorescence microscopy
Themanipulated 5330 strains as described above were grown in
50 l synthetic (SD) medium [0.67% yeast nitrogen base without
amino acids (Conda Pronadisa) and 2% dextrose] containing the
appropriate supplements for selection in 384-well plates (Cat.
Number 781 162, Greiner). Microscopic screening was per-
formed using an automated microscopy set-up as previously
described (9,20). Cells were moved from agar plates into
liquid 384-well polystyrene growth plates using the RoTor
arrayer (Singer). Liquid cultures were grown over night in SD
medium in a shaking incubator (LiCONiC Instruments) at
308C. A JANUS liquid handler (Perkin Elmer), which is con-
nected to the incubator, was used to back-dilute the strains to
0.25 OD into plates containing the same medium. Plates
were then transferred back to the incubator and were allowed
to grow for 3.5 h at 308C to reach the logarithmic growth
phase, as was validated in preliminary calibration. The liquid
handler was then used to transfer strains into glass bottom
384-well microscope plates (Matrical Bioscience) coated with
Concanavalin A (Sigma-Aldrich) to allow cell adhesion. Wells
were washed twice in medium to remove floating cells and
reach cell monolayer. Plates were then transferred into an
automated inverted fluorescent microscopic ScanR system
(Olympus) using a swap robotic arm (Hamilton). Imaging of
plates was performed in 384-well format using a 60× air lens
(NA ¼ 0.9) in SD medium at 248C with a cooled CCD camera
(HamamatsuORCA-ER). Imageswere acquired at GFP (excita-
tion at 490/20 nm, emission at 535/50 nm) andmCherry (excita-
tion at 572/35 nm, emission at 632/60 nm) channels.
Image analysis
Our screening assay was designed to explore yeast cell biology
by assessing two cellular key features of interest: subcellular lo-
calization and fluorescence intensity. To analyse these images,
we have utilized an in-house script to browse manually and
assign localization rapidly and efficiently. To extract proteomic
abundance from images, we utilized the Olympus ScanR ana-
lysis software. This allows for the pre-processing of images by
background subtraction, and segmentation of images to identify
individual cells as separate objects. Data on expression intensity
were compared with a WT library that does not have the Dhrp1
background. In addition,manual inspection of the images allows
us to assign localization for each protein relative to a control
strain.
Zebrafish knockdown
A translation blockingMO directed at the zebrafish hnrpdl gene
(TBMO) (5′-TTCAAA(ATG)CAGGCCGAAGAGCAAG-3′)
was designed against the initiation methionine shown in paren-
thesis. A standard negative control MO (5′-CCTCTTACCTCA
GTTACAATTTATA-3′) was used for control injections. All
MOs were ordered from Gene Tools. Zebrafish were injected
at the 1–2 cell stage with either 6, 9 or 12 and were assessed
for phenotypic changes at 4 days post-fertilization (4 dpf),
each injection was performed three times. Approximately 200
embryos were injected at each dosage.
Birefringence assay
The muscle phenotype was detected by using a birefringence
assay, a technique used to analyse muscle quality due to the
unique ability of highly organized sarcomeres to rotate polarized
light. The birefringence assay is performed by placing anaesthe-
tized embryos on a glass polarizing filter and covering themwith
a second polarizing filter. The filters are placed on an underlit
dissecting scope and the top polarizing filter is twisted until the
light refracting through the zebrafish’s striated muscle is
visible. The fish do not need to be sacrificed for this technique.
Zebrafish immunostaining
Immunostaining was performed in 4 dpf embryos. Embryos
were fixed in 4% paraformaldehyde in PBS at 48C overnight
and dehydrated in 100% methanol. After rehydration, 4 dpf
embryos were incubated in 0.1% collagenase (Sigma) in PBS
for 60 min. Blocking solution containing 0.2% saponin was
used for 4 dpf embryos. Anti-slow muscle MCH antibody
(F59, Developmental Studies Hybridoma Bank; 1:50) was
used. The embryos were placed in 3% methyl cellulose or
mounted on a glass slide and observed with fluorescent micro-
scopes (Nikon Eclipse E1000 and Zeiss Axioplan2).
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